Daily Watch List: Petroleo Brasileiro Petrobras SA (NYSE:PBR), BankFinancial Corp. (NASDAQ:BFIN), Gilead Sciences (NASDAQ:GILD), Atwood Oceanics (NYSE:ATW)

Danaos Corporation (NYSE:DAC) shares fell -2.80% in last trading session and ended the day at $5.21. DAC Gross Margin is 77.80% and its has a return on assets of 1.50%. Danaos Corporation (NYSE:DAC) quarterly performance is -17.82%.

Danaos Corporation (NYSE:DAC) was upgraded by Zacks Investment Research from a “hold” rating to a “strong-buy” rating in a research report issued on Monday, ARN reports. The brokerage currently has a $6.25 price target on the stock. Zacks Investment Research‘s price target indicates a potential upside of 14.47% from the company’s current price.

Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) caters to the Basic Materials space. It has a net profit margin of -2.60% and weekly performance is -10.63%. On the last day of trading company shares ended up at $3.95. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) distance from 50-day simple moving average (SMA50) is -17.32%.

Petroleo Brasileiro SA Petrobras (ADR) (NYSE:PBR), said that, it has remained under immense pressure in 2014 and 2015. The integrated oil and gas major was bombarded with one problem after another.

On 06 January, BankFinancial Corp. (NASDAQ:BFIN) shares fell -0.39% and was closed at $12.72. BFIN EPS growth in last 5 year was 120.60%. BankFinancial Corp. (NASDAQ:BFIN) year to date (YTD) performance is 0.71%.

BankFinancial Corp. (NASDAQ:BFIN) agreed to extend the current share repurchase program to Dec. 31, 2016, and increased the program’s authorized maximum by 1,046,868 shares to 1,297,317 shares of common stock.

Gilead Sciences Inc. (NASDAQ:GILD) shares moved up 1.05% in last trading session and ended the day at $100.30. GILD Gross Margin is 87.30% and its has a return on assets of 41.60%. Gilead Sciences Inc. (NASDAQ:GILD) quarterly performance is 3.27%.

On 2 January, Gilead Sciences Inc. (NASDAQ:GILD) has grown to be a leading biotech company in the past few years, mostly on the back of the phenomenal success of its hepatitis C franchise. The drug-maker’s two revolutionary HCV drugs, Harvoni and Sovaldi, are two of the fastest-growing medicines in history, boasting cure rates of 8-24 weeks, down from a prior 24-48 week treatment period.

Atwood Oceanics, Inc. (NYSE:ATW) caters to the Basic Materials space. It has a net profit margin of 31.00% and weekly performance is -12.69%. On the last day of trading company shares ended up at $9.04. Atwood Oceanics, Inc. (NYSE:ATW) distance from 50-day simple moving average (SMA50) is -37.27%.

Atwood Oceanics, Inc. (NYSE:ATW) announced a cash dividend payment of $0.075 per share is scheduled to be paid on January 13, 2016. Shareholders who purchased ATW prior to the ex-dividend date are eligible for the cash dividend payment. This represents an -70% decrease from the prior quarter.